Skip to main content
. 2022 Jul 21;12(2):1441–1450. doi: 10.1002/cam4.5029

FIGURE 4.

FIGURE 4

Expression of immunohistochemical markers in different ECA subtypes. Each graph shows the positive or aberrant expression rates of CDX2, PAX8, p16, p53, CEA, CLDN18 (M), and CLDN18 (N). (A) Gastric‐type ECA (n = 8). (B) Intestinal‐type ECA (n = 9). (C) iSMILE‐type ECA (n = 8). (D) Usual‐type ECA (n = 33). ECA, endocervical adenocarcinoma.